Novartis

Novartis mulls sale for underperforming Alcon eye division
Mass Device
Mon, 11/14/16 - 10:50 pm
Novartis
Alcon
devices
M&A
The Novartis house that Vasella built gets extreme makeover
Yahoo/Reuters
Mon, 11/14/16 - 10:43 am
Novartis
Daniel Vasella
Alcon
Pfizer wins EU's approval for Ibrance as Novartis readies rival drug
Yahoo/Reuters
Thu, 11/10/16 - 11:21 am
Pfizer
Europe
Ibrance
breast cancer
Novartis
ribociclib
Novartis Takes Aim at Pfizer
Motley Fool
Thu, 11/3/16 - 09:48 am
Novartis
Pfizer
breast cancer
ribociclib
Ibrance
Novartis' Is Challenging Biogen on Biogen's Own Turf
Motley Fool
Wed, 10/26/16 - 09:19 pm
Novartis
Biogen
Gilenya
Tecfidera
MS
multiple sclerosis
Merck and Novartis chiefs outline what’s on the M&A menu in 2017
Endpoints
Wed, 10/26/16 - 09:14 am
Merck
Novartis
M&A
Novartis explains why it canned the cell therapy unit
BioPharma Dive
Wed, 10/26/16 - 09:09 am
Novartis
cell therapy
Novartis promises a speedy CAR-T pitch, boasts about its slate of blockbusters-to-be
Endpoints
Tue, 10/25/16 - 10:10 am
Novartis
CAR-T
CTL-019
acute lymphoblastic leukemia
diffuse large B-cell lymphoma
With no big M&A on tap, Novartis presses pause on $12B-plus Roche stake sale
Fierce Pharma
Mon, 10/24/16 - 11:51 pm
Novartis
M&A
Roche
Novartis’s 3Q16 Estimates: Will Alcon Recover Its Growth?
Market Realist
Mon, 10/24/16 - 11:49 pm
Novartis
Alcon
earnings
Could Pfizer's at-risk Inflectra launch set a biosimilars precedent for Amgen, Novartis?
Fierce Pharma
Mon, 10/24/16 - 09:50 am
Pfizer
drug launches
biosimilars
Inflectra
Amgen
Novartis
Novartis’s 3Q16 Estimates: Innovative Medicines Segment
Market Realist
Mon, 10/24/16 - 09:32 am
Novartis
earnings
What’s to Be Expected from Novartis’s 3Q16 Earnings?
Market Realist
Fri, 10/21/16 - 10:20 pm
Novartis
earnings
Novartis May Be Too Generic
TheStreet.com
Fri, 10/21/16 - 11:39 am
Novartis
generics
patents
Sandoz
Novartis links up with Cerulean in NDC deal
BioPharma Dive
Thu, 10/20/16 - 09:28 am
Novartis
Cerulean
NDCs
drug development
R&D
Earnings guide: A preview of 9 big pharmas in Q3
BioPharma Dive
Wed, 10/19/16 - 11:52 am
earnings
Roche
Merck
Eli Lilly
Novartis
GSK
Bristol-Myers Squibb
Sanofi
Pfizer
AstraZeneca
Eli Lilly’s new psoriasis treatment Taltz launches first ads, chasing Novartis’ Cosentyx lead
Fierce Pharma
Wed, 10/12/16 - 11:33 am
Eli Lilly
psoriasis
Novartis
Cosentyx
Taltz
drug ads
Novartis-backed Gamida Cell grabs a breakthrough trophy for experimental cell treatment
Endpoints
Tue, 10/11/16 - 09:25 pm
Gamida Cell
Novartis
NiCord
bone marrow transplants
breakthrough status
Novartis Targets Breast Cancer Drug Approval to Take on Pfizer
Bloomberg
Sat, 10/8/16 - 03:48 pm
Novartis
Pfizer
breast cancer
ribociclib
Novartis to pay $35 million to settle charges of illegally promoting a drug for infants
Stat/Pharmalot
Thu, 10/6/16 - 09:30 am
Novartis
Elidel
whistleblower lawsuits
off-label

Pages